Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07458672) titled 'TAVR for Aortic Regurgitation Under TTE Guidance' on March 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital

Condition: Aortic Regurgitation Transcatheter Aortic Valve Replacement (TAVR)

Intervention: Procedure: TTE guided TAVR

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 10, 2026

Target Sample Size: 30

To know more, visit https://clinicaltrials.gov/study/NCT07458672

Published by HT Digital...